Asahi Kasei Pharma Open Innovation 2023

Targets:

Autoimmune disease, Renal disease, Pain and Neurodegenerative disease, Bone disease or Platform Technologies for Drug Discovery

GRANT

Up to US$200,000 funding per year for each selected proposal, up to 3 years depending on the research content.

Eligible Candidates:

Researchers from a university or research institute outside Japan (academia, pharmaceutical company, biotech, start-up, etc.).

Students are not accepted.

Application Period: between January 5, 2023, and February 28, 2023.  

Find more detailed info from the website below.

https://www.asahikasei-pharma.co.jp/a-compass/en/recruit.html

===================

Interested in being kept informed of other supports from the EU-Japan Centre?
Feel free to fill in the form at https://www.eu-japan.eu/be-informed

We look forward to receiving your application!